1. Rapporto dell'ANMCO sullo scompenso cardiaco. Banca dati Giofil. 06 dicembre 2000. 2. Hunt et al. Sito internet: www.acc.org/clinical/guidelines/failure/ 3. Vasan RS et al. J Am Coll Cardiol 1995; 26:1565 4. Krumholz HM et al. J Am Coll Cardiol 2003;41:1510-1522. 5. Collins SP et al. Ann Emerg Med 2003; 41:532 6. Del Sindaco D et al. Ital Heart J Suppl 2002;3:145 7. Heiat A et al. Arch Intern Med 2002:162:1682 8. Flather ND et al. Lancet 2000; 355:1575 9. Hunt SA et al. Circulation 2001;104:2996 10.Foody JM et al. JAMA 2002;287:883 11.Studio MERIT-HF (metoprololo). Lancet 1999; 353: 2001 12.Studio CIBIS II (bisoprololo). Lancet 1999; 353: 9 13.Studio COPERNICUS (carvedilolo).N Engl J Med 2001; 344:1651 14.Studio COMET.Lancet 2003;362:7 15.Goldstein S et al.Studio MERIT-HF (analisi a posteriori). J Am Coll Cardiol 2001;38:932 16.Studio ELITE II. Lancet 2000; 355:1582 17.Studio Val HeFT. N Engl J Med 2001; 345:1667 18.. Yusuf S et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003; Sept 6; 362: 777-81 19.Studio VALIANT. N Engl J Med 2003; 349:1839 20. American College of Cardiology 53rd Annual Scientific Session: Session 1069-114. Presented March 8, 2004. 21.Studio DIG. N Engl J Med 1997; 336:525 22.Rathore SS et al. N Engl J Med 2002; 347:1403 23.Rathore SS et al. JAMA 2003; 289:871 24.Studio RALES. N Engl J Med 1999; 341:709 25.Juurlink DN et al. N Engl J Med 2004 ;351:543 26.Cleland JF et al. Lancet 2002; 360:1631 27.Lee VC et al. Ann Intern Med 2004; 141:693-704 28.Bardy GH et al. SCD-HeFT Trial. N Engl J Med 2005; 352:225-237 29.Cleland JGF et al. for the Cardiac Resynchronization - Heart Failure (CARE-HF) Study Investigators. The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure N Engl J Med 2005.Pubblicato online il 7 marzo 2005 30.Doust JA et al. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 2005 Mar 18; 330:625 31. Goldberg Z et al. Implantable Cardioverter-Defibrillators. Expanding Indications and Technologies . JAMA. 2006 Feb 15; 295:809-818. 32. Ahmed A. et al. Eur Heart J 2006 Jan;27:127-129,178-186. 33. Satpathy C. et al. Diagnosis and Management of Diastolic Dysfunction and Heart Failure. Am fam Physician 2006 Mar 1; 73:841-846 34. Faris R et al. Diuretics for heart failure. Cochrane Database Syst Rev 2006;(1):CD003838. Sito internet: http://www.cochrane.org/reviews/en/ab003838.html. Accesso del 5 agosto 2006 35. Tsuyki RT et al. for the APPROACH Investigators. Revascularization in patients with heart failure. CMAJ 2006 Aug 15; 175: 361-365 36. Bhatia RS et al. Outcome of Heart Failure with Preserved Ejection Fraction in a Population-Based Study. N Engl J Med 2006 Jul 20; 355:260-269 37. Owan TE et al. Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction. N Engl J Med 2006 Jul 20; 355:251-259 38. Bursi F et al. Systolic and diastolic heart failure in the community. JAMA 2006 Nov 8; 296:2209-16. 39. Gheorghiade M et al. or the OPTIMIZE-HF Investigators and Coordinators. Systolic Blood Pressure at Admission, Clinical Characteristics, and Outcomes in Patients Hospitalized With Acute Heart Failure. JAMA. 2006 Nov 8;296:2217-2226. 40. Cleland JGF et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 2006 Oct; 27: 2338-2345 41. 1. Dobrea D et al. Prescription of beta-blockers in patients with advanced heart failure and preserved left ventricular ejection fraction. Clinical implications and survival. European Journal of Heart Failure, avaible online 2006 October 5, doi:10.1016/j.ejheart.2006.07.008 42. Ahmed A et al. Effects of Digoxin on Morbidity and Mortality in Diastolic Heart Failure. The Ancillary Digitalis Investigation Group Trial". Circulation. 2006;114:397-403 43. Ezekowitz JA et al. Systematic Review: Implantable Cardioverter Defibrillators for Adults with Left Ventricular Systolic Dysfunction. Ann Intern Med 2007 Aug 21; 147:251-262
|
|
